汉森制药

- 002412

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
汉森制药(002412) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入25,403.2595,553.0868,414.1847,167.2425,017.80
营业收入25,403.2595,553.0868,414.1847,167.2425,017.80
二、营业总成本19,371.5878,424.3761,570.0141,511.9120,267.70
营业成本6,544.5625,589.4218,786.4513,401.747,295.92
营业税金及附加520.601,890.881,366.04942.10473.50
销售费用10,255.3739,468.3334,681.6222,700.7010,184.52
管理费用1,221.396,835.723,524.592,227.911,016.88
财务费用41.07192.10199.07123.5866.32
研发费用788.594,447.923,012.242,115.881,230.56
资产减值损失----------
公允价值变动收益36.92179.60128.1990.0558.90
投资收益458.706,114.994,410.314,059.761,305.65
其中:对联营企业和合营企业的投资收益399.975,775.194,110.203,844.601,229.40
汇兑收益----------
三、营业利润6,801.0623,493.7311,696.4710,011.846,271.23
加:营业外收入3.3762.5448.5435.377.97
减:营业外支出10.72954.5436.1032.450.18
其中:非流动资产处置损失----------
四、利润总额6,793.7122,601.7311,708.9110,014.766,279.02
减:所得税费用967.252,100.24734.68948.04772.27
五、净利润5,826.4720,501.4910,974.239,066.725,506.75
归属于母公司所有者的净利润5,826.4720,501.4910,974.239,066.725,506.75
少数股东损益----------
六、每股收益
基本每股收益(元/股)0.11580.40740.21810.18020.1094
稀释每股收益(元/股)0.11580.40740.21810.18020.1094
七、其他综合收益613.391,484.241,127.691,146.83559.14
八、综合收益总额6,439.8521,985.7212,101.9210,213.546,065.89
归属于母公司所有者的综合收益总额6,439.8521,985.7212,101.9210,213.546,065.89
归属于少数股东的综合收益总额----------
下载全部历史数据到excel中 返回页顶